Takuya Kobayakawa

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineChemistryPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application”.

Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application

ACS Medicinal Chemistry Letters(2018)10.1021/acsmedchemlett.7b00234

N/A

0.477DataRank · unranked

23 citations

Yudai Matsuzaki, Kentaro Hozumi, Wataru Nomura, Motoyoshi Nomizu, Hirokazu Tamamura +1 more

Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement

Chemical and Pharmaceutical Bulletin(2023)10.1248/cpb.c23-00562

N/A

0.330DataRank · unranked

8 citations

Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi‐Kuwata, Chika Azuma, Kouki Shinohara +8 more

Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115449

N/A

0DataRank · unranked

10 citations

Takuya Kobayakawa, Kouki Matsuda, Kohei Tsuji, Nami Ohashi, Shingo Nakahata +6 more

Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates

Journal of Virology(2022)10.1128/jvi.01638-22

N/A

0DataRank · unranked

7 citations

Takeo Kuwata, William D. Tolbert, Jonathan Richard, Shilei Ding, Jérémie Prévost +12 more

SARS-CoV-2 Papain-Like Protease Inhibitors Based on Naphthalen-1-ylethanamine and Halogenated Benzene Moieties

ACS Omega(2025)10.1021/acsomega.5c05856

N/A

0DataRank · unranked

2 citations

Takuya Kobayakawa, Kohei Tsuji, Yuki Takamatsu, Hiroaki Mitsuya, Hirokazu Tamamura +1 more

SARS-CoV-2 Main Protease Inhibitors Containing 5-Substituted Benzothiazole-2-carbonyl Moieties at the P1′ Site and Their Derivatives

ACS Omega(2025)10.1021/acsomega.5c05168

N/A

0DataRank · unranked

0 citations

Takuya Kobayakawa, Nobuyo Higashi‐Kuwata, Takahiro Ishii, Kouki Shinohara, Ryusei Yamamoto +5 more

An orally available P1′-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier

PNAS Nexus(2024)10.1093/pnasnexus/pgae578

N/A

0DataRank · unranked

9 citations

Haydar Bulut, Hironori Hayashi, Kohei Tsuji, Hiromi Ogata-Aoki, Maki Kiso +23 more

Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

Nature Communications(2023)10.1038/s41467-023-36729-0

N/A

0DataRank · unranked

45 citations

Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai +30 more